RP Bio Inc. (KOSDAQ:314140)
5,760.00
-180.00 (-3.03%)
At close: Oct 2, 2026
| Market Cap | 49.92B -20.7% |
| Revenue (ttm) | 141.42B +9.6% |
| Net Income | 6.73B +121.6% |
| EPS | 777.21 +120.9% |
| Shares Out | 8.67M |
| PE Ratio | 7.41 |
| Forward PE | n/a |
| Dividend | 50.00 (0.87%) |
| Ex-Dividend Date | Dec 29, 2025 |
| Volume | 19,350 |
| Open | 5,880.00 |
| Previous Close | 5,940.00 |
| Day's Range | 5,760.00 - 5,910.00 |
| 52-Week Range | 4,810.00 - 9,130.00 |
| Beta | 0.42 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |